According to Redhill Biopharma's latest financial reports the company's current earnings (TTM) are C$15.69 M. In 2022 the company made an earning of -C$97.22 M an increase over its 2021 earnings that were of -C$0.14 B.The earnings displayed on this page is the company's Pretax Income.